You are here
Key international figures
- No. 1 independent French pharmaceutical company
- Over 21,000 employees, including nearly 3,000 researchers preparing the drugs of the future
- In 2015, 24% of Servier's turnover was invested in Research & Development
- Servier is currently developing 23 drug candidates in oncology, cardiology, metabolic diseases, neuropsychiatry and rheumatology
- Present in 148 countries over 5 continents
- 92% of Servier's medicines are prescribed outside France
- A turnover of 3.9 billion euros in 2015